Skip to main content
HR logo

HR · Healthcare Realty Trust Inc

Track HR — free
$19.13 -0.13 (-0.67%) At close · Aug 27
Market Cap
$6.56B
Shares
342.72M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$19.13 Open$19.17 Day$19.07–19.21 52W close$16.34–21.87 Avg vol 30d3.5M Short int17.0M · 5.0% float · 4.5d Short vol56% Last earningsJul 31, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 30, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 30, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Bullish Fundamentals Fair Quant / Vol Very Low
      Market backdrop VIX 14.5 · calm Equity put/call 0.39
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +2%
      above
      Price vs 50-day avg −6%
      below
      RSI (14) 33
      neutral
      MACD trend Negative
      52-week position 50%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return −11%
      trailing
      6-month return +4%
      trailing
      YTD return +13%
      this year
      Relative strength −11%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $20 › 200d $19 — 50d above 200d
      Institutional flow Accumulating
      +2% holders QoQ · +60 funds added
      Insider flow Distributing
      Net -$524.9K over 90 days · 100% sells
      Short interest Falling
      4.96% of float · ▼ -9.0% MoM · 4.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      457 holders — near 3-yr high, broad support
      Squeeze score 55
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth −7%
      Y/Y
      EPS growth +61%
      Y/Y
      Buyback $400.1M
      remaining
      Balance sheet $3.9B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 20%
      annualized · 1-yr
      Max drawdown −13%
      past year
      ATR 1.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 30, 2026
      Normalized FFO per share · full year 2026 Initiated $1.62 – $1.66
      Same Store Cash NOI growth · full year 2026 Initiated 4.25% – 5%
      Prior guidance period ended · from the 8-K filed Oct 30, 2025
      NAREIT FFO per share · Expected 2025 $1.39 – $1.41
      Normalized FFO per share · Expected 2025 $1.59 – $1.61
      Same Store Cash NOI growth · Expected 2025 4% – 4.75%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +2% Bullish
      Price vs 50-day avg
      −6% Bearish
      RSI (14)
      33 Neutral
      MACD trend
      Negative Bearish
      52-week position
      50% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $20 › 200d $19 — 50d above 200d
      Institutional flow Accumulating
      +2% holders QoQ · +60 funds added
      Insider flow Distributing
      Net -$524.9K over 90 days · 100% sells
      Short interest Falling
      4.96% of float · ▼ -9.0% MoM · 4.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      457 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $16 Now $19 · 50% Range high $22
      vs 200-day avg +2% vs 50-day avg -6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      % of Cash NOI in Company's Top 20 Markets 77% Q2 2026
      Cash leasing spreads (renewals) 4.8% Q2 2026
      GAAP → non-GAAP reconciliation
      GAAP Normalized FFO 143.7M
      +789K Non-real estate depreciation and amortization
      +1.38M Non-cash interest amortization, net
      -13.72M Straight-line amortization, net
      +4.42M Stock-based compensation
      -164K Unconsolidated JV non-cash items
      -27.05M Maintenance capex
      = FAD 109.36M
      Fully Diluted Shares and Units 346.96M Q2 2026
      Net Debt to Enterprise Value 37% Q2 2026
      Shares repurchased 3.8M second quarter 2026
      Tenant retention rate (renewals) 88.5% Q2 2026
      % of Cash NOI in Top 20 Markets non-GAAP 77% Q1 2026
      % Variable Rate Debt 7.2% 1Q 2026
      Adjusted EBITDA non-GAAP $184.83M 1Q 2026
      GAAP → non-GAAP reconciliation
      GAAP EBITDA 181.32M
      +937K Transaction costs
      -10.78M Gain on sales of assets
      +16K Impairments on real estate assets
      +5.84M Restructuring and severance-related charges
      +21K Loss on extinguishment of debt
      +2.6M Timing impact
      +3.93M Stock based compensation
      +96K Debt financing costs
      +507K Other
      +339K Unconsolidated JV adjustments
      = Adjusted EBITDA 184.83M
      Annualized Adjusted EBITDA non-GAAP $739.31M 1Q 2026
      Capitalized interest $3.47M 1Q 2026
      Leverage ratio 38.1% 1Q 2026
      New and renewal leases executed 291 Q1 2026
      New lease commitments as a % of annual net rent 46.9% 1Q 2026
      New leases SF 286,314 1Q 2026
      Renewal commitments as a % of annual net rent 13% 1Q 2026
      Renewals SF 1,725,651 1Q 2026
      Same store number of properties 529 1Q 2026
      Same store occupancy 92.3% 1Q 2026
      Secured leverage ratio 0.2% 1Q 2026
      Share of Unconsolidated JV Net Debt $34.03M 1Q 2026
      Square feet 32,883,258 1Q 2026
      Total development budget $106.2M 1Q 2026
      Total development cost to complete $13.04M 1Q 2026
      Total development leased % 60% 1Q 2026
      Total development square feet 224,270 1Q 2026
      Total lease executions SF 2,011,965 1Q 2026
      Total leasing commitments as a % of annual net rent 16.1% 1Q 2026
      Total liquidity $1.22B 1Q 2026
      Total redevelopment budget $287.7M 1Q 2026
      Total redevelopment cost to complete $183.93M 1Q 2026
      Total redevelopment count 23 1Q 2026
      Total redevelopment project leased % 64% 1Q 2026
      Total redevelopment project square feet 1,434,891 1Q 2026
      Total redevelopment square feet 2,070,746 1Q 2026
      Total shares and OP units outstanding 350,785,034 1Q 2026
      Unencumbered leverage ratio 41.8% 1Q 2026
      WALT (months) - Occupied 64.5 1Q 2026
      WALT (months) - Total 94.3 1Q 2026
      Asset sales $1.2B Full year 2025 (through February 2026)
      Average annual escalators 3% Q4 2025
      Blended cap rate 6.7% Full year 2025 (through February 2026)
      Commercial paper program size $600M February 12, 2026
      Diluted WA shares outstanding 354.9M 4Q 2025
      Enterprise value $10.1B as of 12/31/25
      Lease executions square feet 5.8M Full year 2025
      Leases executed 292 Q4 2025
      Liquidity $1.4B Q4 2025
      Market capitalization $6B as of 12/31/25
      New lease executions square feet 1.6M Full year 2025
      NOI in Top 15 Markets 65% 4Q 2025
      Number of disposition transactions 34 Full year 2025 (through February 2026)
      Number of properties (Total) 562 4Q 2025
      Period end occupancy 92.1% 4Q 2025
      Properties 562 4Q 2025
      Repaid senior notes $250M Full year 2025
      Repaid term loans $650M Full year 2025
      Revenue per occ SF non-GAAP $38.31 4Q 2025
      Run-rate G&A expense reduction $10M Full year 2025
      Same store Cash NOI Margin non-GAAP 64.4% 4Q 2025
      Share repurchase average price $17.27 January 2026
      Share repurchase total $50M January 2026
      Shares/units outstanding 355.9M as of 12/31/25
      Term loans repaid in fourth quarter $542M Q4 2025
      Total cash NOI non-GAAP $178.46M 4Q 2025
      Total shares outstanding 355,878,607 As of December 31, 2025
      Total square footage 32.7M 4Q 2025
      Weighted average lease term 6.2 Q4 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HR
      Healthcare Realty Trust Inc
      this stock
      $6.56B +12.9% -6.9% 5.0%
      WELL
      Welltower Inc.
      $170.52B +29.1% +35.6% 120.2 2.5%
      VTR
      Ventas, Inc.
      $47.96B +20.0% +18.5% 173.2 4.6%
      DOC
      Healthpeak Properties, Inc.
      $14.66B +32.0% +4.5% 60.7 3.3%
      OHI
      Omega Healthcare Investors Inc
      $14.25B +4.4% +13.2% 16.7 4.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      457
      % held
      111.5%
      Net QoQ
      +7.2M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      379
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      17.0M
      Days to cover
      4.5d
      Change
      -1.7M sh
      View
      Short Volume
      Short vol %
      56%
      As of
      Aug 27, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      90
      Value
      $2.0K
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      34.8%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$524.9K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Zoe Lofgren
      Amount
      $1.0K–$15.0K
      Traded
      Mar 23, 2020
      View
      Financials
      Financials
      Revenue (FY)
      $1.2B
      Net income (FY)
      $-246.1M
      EPS diluted
      $-0.71
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $400.1M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 31, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $262.1K
      Shares
      15.0K
      Filed
      Sep 4, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 31, 2026
      View
      Investor Relations
      Latest news
      Healthcare Realty Reports Second…
      Published
      Jul 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      HR -1.4% -11.2% +4.0% -9.0% +12.9%
      SPY +1.1% +4.0% +14.7% +3.2% +13.1%
      vs SPY -2.6% -15.1% -10.7% -12.2% -0.2%

      Capital returns

      Latest dividend
      $0.24 / share · ex Aug 11, 2026
      Cut 22.6%
      Paid (TTM)
      $0.96 / share · 4 payouts
      Dividend yield (TTM, derived)
      5.02%
      Buyback program · as of Jun 30, 2026
      Authorized
      $500.00M
      Spent (derived)
      $99.90M
      Remaining
      $400.10M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1360604 CUSIP 42226K105 13F (30d) 359 filings 355 filers Visit website Investor relations